InvestorsHub Logo

fredman

02/08/19 10:48 AM

#51 RE: Jt0082 #50

I think you might to have to ask someone else on the board that is more knowledgeable on the subject.

I very well do believe we are looking at some serious potential upside from here moving forward.

You are correct, PAD is a bonus! Potentially for everyone that hangs on for the long term! GLTA

Whalatane

02/13/19 6:17 PM

#52 RE: Jt0082 #50

Jt. responded to you on the AMRN site ...which will probably be deleted

Yes I have a small position in PRTO . If successful will be a low cost add on ( $400 ) during the surgical procedure to create new fistula's.

Am wondering about Avenue Medical tho and how fast their non surgical fistula creation system is being adopted. It got a lot of attention at a recent Nephro conference

Kiwi

Whalatane

02/13/19 7:43 PM

#53 RE: Jt0082 #50

Jt. great info re Avenu Medical and guidelines for RC AVF.

Re my wife's connection . The head of her Renal Dept asks her to screen patients for clinical trials. So over the years she has recruited patients for FGEN trials and PRTO.
Regarding PRTO ...her view from memory ....one of the top vascular surgeons at her hospital is in charge of the trial here.
Will not need to show an enormous improvement to be clinically meaningful ...and apparently its low cost ...$400-$600 per fistula .
Time from AVF creation to abandonment is the key end pt ...correct ?

I have just a small long position and have not paid much attention to it since the head of her Dept started gushing over the Avenu Medical system ....but will chk in with her again based on the guideline information you posted .
thx
Kiwi